Program highlights
The Story of Precision Medicine
A resource for all stakeholders in the Precision Medicine space to learn more about Precision Medicine, what it is, its history and application in real-life, including patient experiences and stories..
Program update – June 2023
Here is an update on the latest developments and news in FT3. Please help us by sharing this update with your network, and thank you for your continued support in helping us make precision medicine a more accessible reality for patients!
As the FT3 Country Pilots continue to advance, on behalf of the local steering groups I’m pleased to provide you with an update on the ongoing pilots in Spain and Hungary.
In the UK, ALK-positive #lungcancer affects 4% of cases, impacting about 8,000 individuals. Debra Montague from @UKALK1 emphasizes the importance of #biomarkertesting & our adapted resource's role in aiding informed decisions. Read Debra's insights: #LCAM
About us
Our motivation
All patients deserve access to the right testing & treatment at the right time. While Precision Medicine (PM) can transform lives, its potential benefits have not yet been fully realized.
Our ambition
Our goal is to improve access to precision medicine for all patients who could benefit from it, by generating better evidence, creating awareness and building the conditions for better access, starting with testing and cancer.
The partnership
We are an independent, nonprofit, global and multistakeholder consortium, building solutions with patients, for patients. Its members and community include individual patients, patient organizations, pharmaceutical & diagnostics companies, healthcare professionals and medical societies, payers, HTA bodies and regulators.
Keep up to date with developments from the precision medicine ecosystem
We don’t spam. Just key info at the right time.
Members
